# Tenet Healthcare Corp: financial statements, quarterly

THC · NYSE · CIK 70318 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/thc.md) · [Financials](/companies/thc/financials.md) · [Filings](/companies/thc/filings.md) · [Insiders](/companies/thc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/thc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,395 d](/filings/0000070318-26-000012.md) | [5,368](/filings/0000070318-25-000017.md) | [5,108](/filings/0000070318-25-000039.md) | [5,126](/filings/0000070318-25-000046.md) | [5,073 d](/filings/0000070318-26-000012.md) | [5,223](/filings/0000070318-26-000026.md) | [5,271](/filings/0000070318-26-000037.md) | [5,289](/filings/0000070318-26-000050.md) | [5,527 d](/filings/0000070318-26-000012.md) | [5,368](/filings/0000070318-26-000026.md) | [5,628](/filings/0000070318-26-000037.md) | [5,631](/filings/0000070318-26-000050.md) |
| Operating income | $m | [735 d](/filings/0000070318-26-000012.md) | [3,285](/filings/0000070318-25-000017.md) | [761](/filings/0000070318-25-000039.md) | [1,089](/filings/0000070318-25-000046.md) | [821 d](/filings/0000070318-26-000012.md) | [943](/filings/0000070318-26-000026.md) | [823](/filings/0000070318-26-000037.md) | [889](/filings/0000070318-26-000050.md) | [853 d](/filings/0000070318-26-000012.md) | [1,296](/filings/0000070318-26-000026.md) | [1,501](/filings/0000070318-26-000037.md) | [1,750](/filings/0000070318-26-000050.md) |
| Interest expense | $m | [227 d](/filings/0000070318-24-000016.md) | [218](/filings/0000070318-24-000032.md) | [203](/filings/0000070318-25-000039.md) | [202](/filings/0000070318-25-000046.md) | [203 d](/filings/0000070318-26-000012.md) | [204](/filings/0000070318-26-000026.md) | [206](/filings/0000070318-26-000037.md) | [206](/filings/0000070318-26-000050.md) | [205 d](/filings/0000070318-26-000012.md) | [205](/filings/0000070318-26-000026.md) | [204](/filings/0000070318-26-000037.md) | [203](/filings/0000070318-26-000050.md) |
| Income tax | $m | [63.0 d](/filings/0000070318-26-000012.md) | [750](/filings/0000070318-25-000017.md) | [110](/filings/0000070318-25-000039.md) | [241](/filings/0000070318-25-000046.md) | [83.0 d](/filings/0000070318-26-000012.md) | [143](/filings/0000070318-26-000026.md) | [120](/filings/0000070318-26-000037.md) | [133](/filings/0000070318-26-000050.md) | [37.0 d](/filings/0000070318-26-000012.md) | [226](/filings/0000070318-26-000026.md) | [295](/filings/0000070318-26-000037.md) | [360](/filings/0000070318-26-000050.md) |
| Net income | $m | [456 d](/filings/0000070318-26-000012.md) | [2,334](/filings/0000070318-25-000017.md) | [477](/filings/0000070318-25-000039.md) | [681](/filings/0000070318-25-000046.md) | [572 d](/filings/0000070318-26-000012.md) | [622](/filings/0000070318-26-000026.md) | [522](/filings/0000070318-26-000037.md) | [579](/filings/0000070318-26-000050.md) | [644 d](/filings/0000070318-26-000012.md) | [906](/filings/0000070318-26-000026.md) | [1,045](/filings/0000070318-26-000037.md) | [1,219](/filings/0000070318-26-000050.md) |
| Diluted EPS | $ per share | not reported | [21.38](/filings/0000070318-25-000017.md) | [2.64](/filings/0000070318-25-000039.md) | [4.89](/filings/0000070318-25-000046.md) | not reported | [4.27](/filings/0000070318-26-000026.md) | [3.14](/filings/0000070318-26-000037.md) | [3.86](/filings/0000070318-26-000050.md) | not reported | [8.01](/filings/0000070318-26-000026.md) | [9.84](/filings/0000070318-26-000037.md) | [12.41](/filings/0000070318-26-000050.md) |
| Basic EPS | $ per share | not reported | [21.60](/filings/0000070318-25-000017.md) | [2.66](/filings/0000070318-25-000039.md) | [4.93](/filings/0000070318-25-000046.md) | not reported | [4.31](/filings/0000070318-26-000026.md) | [3.16](/filings/0000070318-26-000037.md) | [3.89](/filings/0000070318-26-000050.md) | not reported | [8.09](/filings/0000070318-26-000026.md) | [9.89](/filings/0000070318-26-000037.md) | [12.48](/filings/0000070318-26-000050.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.2](/filings/0000070318-25-000009.md) | [2.5](/filings/0000070318-24-000032.md) | [2.9](/filings/0000070318-24-000041.md) | [4.1](/filings/0000070318-24-000052.md) | [3.0](/filings/0000070318-26-000012.md) | [3.0](/filings/0000070318-25-000017.md) | [2.6](/filings/0000070318-25-000039.md) | [3.0](/filings/0000070318-25-000046.md) | [2.9](/filings/0000070318-26-000050.md) | [3.0](/filings/0000070318-26-000026.md) | [2.2](/filings/0000070318-26-000037.md) | [2.7](/filings/0000070318-26-000050.md) |
| Current assets | $bn | [7.2](/filings/0000070318-25-000009.md) | [7.8](/filings/0000070318-24-000032.md) | [8.0](/filings/0000070318-24-000041.md) | [8.8](/filings/0000070318-24-000052.md) | [7.7](/filings/0000070318-26-000012.md) | [7.9](/filings/0000070318-25-000017.md) | [7.3](/filings/0000070318-25-000039.md) | [7.8](/filings/0000070318-25-000046.md) | [7.8](/filings/0000070318-26-000050.md) | [8.4](/filings/0000070318-26-000026.md) | [7.8](/filings/0000070318-26-000037.md) | [8.4](/filings/0000070318-26-000050.md) |
| Total assets | $bn | [28.3](/filings/0000070318-26-000012.md) | [28.9](/filings/0000070318-24-000032.md) | [29.3](/filings/0000070318-24-000041.md) | [29.4](/filings/0000070318-24-000052.md) | [28.9](/filings/0000070318-26-000012.md) | [29.2](/filings/0000070318-25-000017.md) | [28.7](/filings/0000070318-25-000039.md) | [29.4](/filings/0000070318-25-000046.md) | [29.7](/filings/0000070318-26-000050.md) | [31.2](/filings/0000070318-26-000026.md) | [30.7](/filings/0000070318-26-000037.md) | [31.6](/filings/0000070318-26-000050.md) |
| Current liabilities | $bn | [4.8](/filings/0000070318-25-000009.md) | [5.4](/filings/0000070318-24-000032.md) | [5.5](/filings/0000070318-24-000041.md) | [5.5](/filings/0000070318-24-000052.md) | [4.3](/filings/0000070318-26-000012.md) | [4.5](/filings/0000070318-25-000017.md) | [4.3](/filings/0000070318-25-000039.md) | [4.6](/filings/0000070318-25-000046.md) | [4.5](/filings/0000070318-26-000050.md) | [6.2](/filings/0000070318-26-000026.md) | [5.6](/filings/0000070318-26-000037.md) | [5.3](/filings/0000070318-26-000050.md) |
| Total liabilities | $bn | [22.8](/filings/0000070318-25-000009.md) | [21.2](/filings/0000070318-24-000032.md) | [21.4](/filings/0000070318-24-000041.md) | [21.3](/filings/0000070318-24-000052.md) | [20.4](/filings/0000070318-26-000012.md) | [20.6](/filings/0000070318-25-000017.md) | [20.4](/filings/0000070318-25-000039.md) | [20.7](/filings/0000070318-25-000046.md) | [20.7](/filings/0000070318-26-000050.md) | [22.4](/filings/0000070318-26-000026.md) | [22.0](/filings/0000070318-26-000037.md) | [22.0](/filings/0000070318-26-000050.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.6](/filings/0000070318-25-000009.md) | [3.5](/filings/0000070318-24-000032.md) | [3.5](/filings/0000070318-24-000041.md) | [3.8](/filings/0000070318-24-000052.md) | [4.2](/filings/0000070318-26-000012.md) | [4.2](/filings/0000070318-25-000017.md) | [3.7](/filings/0000070318-25-000039.md) | [4.0](/filings/0000070318-25-000046.md) | [4.2](/filings/0000070318-26-000050.md) | [4.8](/filings/0000070318-26-000026.md) | [4.7](/filings/0000070318-26-000037.md) | [5.4](/filings/0000070318-26-000050.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [824 d](/filings/0000070318-26-000012.md) | [586](/filings/0000070318-25-000017.md) | [747 d](/filings/0000070318-25-000039.md) | [1,045 d](/filings/0000070318-25-000046.md) | [(331) d](/filings/0000070318-26-000012.md) | [815](/filings/0000070318-26-000026.md) | [936 d](/filings/0000070318-26-000037.md) | [1,058 d](/filings/0000070318-26-000050.md) | [731 d](/filings/0000070318-26-000012.md) | [1,641](/filings/0000070318-26-000026.md) | [585 d](/filings/0000070318-26-000037.md) | [1,281 d](/filings/0000070318-26-000050.md) |
| Capital expenditure | $m | [208 d](/filings/0000070318-26-000012.md) | [240](/filings/0000070318-25-000017.md) | [145 d](/filings/0000070318-25-000039.md) | [216 d](/filings/0000070318-25-000046.md) | [330 d](/filings/0000070318-26-000012.md) | [173](/filings/0000070318-26-000026.md) | [193 d](/filings/0000070318-26-000037.md) | [280 d](/filings/0000070318-26-000050.md) | [364 d](/filings/0000070318-26-000012.md) | [180](/filings/0000070318-26-000026.md) | [168 d](/filings/0000070318-26-000037.md) | [198 d](/filings/0000070318-26-000050.md) |
| Share repurchases | $m | [110 d](/filings/0000070318-26-000012.md) | [278](/filings/0000070318-25-000017.md) | [270 d](/filings/0000070318-25-000039.md) | [124 d](/filings/0000070318-25-000046.md) | [0.0 d](/filings/0000070318-26-000012.md) | [348](/filings/0000070318-26-000026.md) | [747 d](/filings/0000070318-26-000037.md) | [93.0 d](/filings/0000070318-26-000050.md) | [198 d](/filings/0000070318-26-000012.md) | [318](/filings/0000070318-26-000026.md) | [1,042 d](/filings/0000070318-26-000037.md) | [255 d](/filings/0000070318-26-000050.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [106](/filings/0000070318-24-000032.md) | [105](/filings/0000070318-24-000041.md) | [104](/filings/0000070318-24-000052.md) | [101](/filings/0000070318-25-000017.md) | [98.4](/filings/0000070318-25-000039.md) | [96.7](/filings/0000070318-25-000046.md) | [95.0](/filings/0000070318-26-000026.md) | [91.8](/filings/0000070318-26-000037.md) | [88.6](/filings/0000070318-26-000050.md) | [87.6](/filings/0000070318-26-000026.md) | [84.0](/filings/0000070318-26-000037.md) | [80.6](/filings/0000070318-26-000050.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 79,588,000 at 2026-10-23, from the cover of the [10-Q filed 2026-10-29](/filings/0000070318-26-000050.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:13 ET. No prices; not investment advice.